Crossmark

Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s13048-024-01576-0

Published Online: 2024-12-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lin, Lijun

Chen, Ge

Qiao, Xiaoyong

Chen, Yan

Deng, Hongxia

Xu, Liangzhi
Funding

Funding for this research was provided by:

the National Natural Science Foundation of China (81971354, 81971354, 81971354)
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Received: 23 July 2024

Accepted: 9 December 2024

First Online: 19 December 2024

Declarations

:

: Not applicable, as this research does not involve direct patient or animal contact.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below